Showing a significant efficacy signal in a phase II trial, Relay Therapeutics Inc.’s zovegalisib (RLY-2608) achieved a 60% volumetric response – more than double than expected – in patients with ...

Eli Lilly LLY-1.21%decrease; down pointing triangle Chief Executive Dave Ricks was on stage with Nvidia NVDA 2.95%increase; up pointing triangle founder Jensen Huang earlier this year in San Francisco ...

We watched the sun go down in Islamabad and then come up again as these marathon talks went on. To end without a deal marks a fundamental blow to nascent hopes of finding an off-ramp to this crisis.

Doctors at the Veterans Affairs Department have yet to receive a pay bump despite a recent law authorizing the increases, which has drawn bipartisan criticism from lawmakers. Currently, VA doctors are ...

Relay for Life set for May 2 at the Kern County Fairgrounds US interdicts stateless sanctioned tanker sailing from Iran to China Senate GOP unveils $70B immigration plan to circumvent Democrats in bid ...

Nextech Invest increased its stake in Relay Therapeutics by 855,097 shares; the estimated trade value was ~$6.1 million based on average quarterly pricing. Quarter-end position value rose by $19.7 ...

Immutep and the Australian biotech’s investors have been caught off guard by the unexpected failure of its LAG-3 candidate in a phase 3 study. The Sydney-based company had been evaluating the ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Drinking water supply is at risk for more than 64,000 people in ...

A Theravance researcher at work. Theravance Biopharma said it is chopping its workforce by 50% and launching a review of strategic alternatives designed to maximize shareholder value, after its sole ...

Washington — President Trump announced Friday that he is ordering all federal agencies to "immediately" stop using Anthropic's artificial intelligence technology, as the company neared a Pentagon ...

SAN FRANCISCO--(BUSINESS WIRE)--#SUD--Baseline Therapeutics, Inc. (“Baseline”), a clinical-stage biotechnology company developing addiction therapeutics, today announced the launch of the company to ...